Schrodinger Q1 2026: Hosted Licensing Progress and ACV Growth Highlighted
Schrodinger (NASDAQ:SDGR) reported first-quarter 2026 results, highlighting progress in its transition to hosted software licensing, growth in annual contract value (ACV), and recent business development activity tied to its drug discovery collaborations.
Key Numbers
Schrodinger (NASDAQ:SDGR) reported first-quarter 2026 results, highlighting progress in its transition to hosted software licensing, growth in annual contract value (ACV), and recent business development activity tied to its drug discovery collaborations.
Key Financial Metrics
| Metric | Q1 2026 |
|---|---|
| Revenue | Not yet disclosed |
| Net Income | Not yet disclosed |
| EPS | Not yet disclosed |
| Annual Contract Value (ACV) | Notable growth |
Highlights from the Report
- Hosted Licensing Transition: Schrodinger continues shifting from traditional licenses to a hosted model, providing recurring revenue streams.
- ACV Growth: The company reported growth in annual contract value, a key indicator of subscription model success.
- Business Development Activity: Drug discovery collaborations saw increased activity, strengthening the company's position in this area.
Future Guidance
Schrodinger did not provide specific numerical guidance for the next quarter but reaffirmed its commitment to continuing the hosted licensing transition and expanding its customer base.
Impact on Stock
SDGR stock did not show significant movement following the announcement, as investors await full financial details. The stock is trading at previous levels.
What This Means for Investors
The shift to hosted licensing is a positive step toward more stable recurring revenue. However, investors should wait for the complete financial report to assess performance accurately.
Frequently Asked Questions
Found this useful? Share it